Event Calendar

Previous month Previous day Next day Next month
By Year By Month By Week Today Search Jump to month


Regional Symposium (University of Miami)      
Tuesday, March 31, 2015 6:15 – 9:30      

Navigating the New Era of IPF: Collaborative Patient Care

Tuesday, March 31, 2015
6:15–9:30 PM
University of Miami Hospital
Seminar Center
First Floor, South Building of the Hospital
1400 NW 12th Avenue
Miami, Florida


Sponsored by The France Foundation and the Pulmonary Fibrosis Foundation.

Supported by an educational grant from InterMune.


  • Exploring ILDs
  • Diagnosing IPF
  • Pathophysiology of IPF and Recent Clinical Trials
  • Comorbidities and Complications of IPF
  • Patient Monitoring, Management, and the Coordination of Care
  • Problem-based Learning Cases

Marilyn K. Glassberg, MD
Professor of Medicine and Surgery
Director, Interstitial Lung Disease Program
University of Miami Miller School of Medicine

Target Audience: This activity is intended for physicians, surgeons, critical care clinicians, advanced practice nurses, and other health care professionals involved in the diagnosis and management of patients with IPF.

Statement of Need: Idiopathic pulmonary fibrosis (IPF) is characterized by progressive worsening of dyspnea and lung function and is associated with a poor prognosis. Today, median survival time from diagnosis of IPF is two to five years. In 2011 an international committee of the American Thoracic Society (ATS) and European Respiratory Society (ERS) published updated guidelines for the diagnosis and management of patients with IPF. There are still challenges for health care providers who treat patients with IPF. These include acute exacerbations and comorbid conditions commonly seen in patients with IPF. In October 2014 the FDA approved two new drugs for the treatment of IPF. These therapies transform the management of IPF and present new options for practitioners and patients.

Educational Activity Learning Objectives 
Upon completion of this course, the participants should be able to:

  • Explain the considerations associated with clinical evaluation, imaging, and surgical biopsy, in terms of differentially diagnosing IPF
  • Identify opportunities for interdisciplinary collaboration and consultation and key aspects of guideline recommendations that can facilitate early and accurate IPF diagnosis
  • Summarize the current understanding of the IPF disease process and strategies that can help measure disease progression and treatment response
  • Identify approaches to IPF management that are covered in current guidelines, taking into account the strength of relevant recommendations
  • Formulate a plan, based on available data and expert consensus, for addressing acute exacerbations of IPF
  • Evaluate clinical trial data on available and emerging treatments for IPF and potential application to practice
  • Formulate a plan for regular and relevant communication with and education of patients and families regarding both pharmacologic and nonpharmacologic aspects of care
  • Explain the impact and treatment of common comorbidities of IPF
  • Identify opportunities for referral to others as part of the multidisciplinary IPF management plan

Accreditation/Designation Statements:
 The France Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation 
 The France Foundation designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure: The France Foundation and the Pulmonary Fibrosis Foundation adhere to ACCME Essential Areas, Standards, and Policies regarding industry support of continuing medical education. Disclosure of the planning committee, content reviewers, and faculty’s commercial relationships will be made known at the activity. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.

Resolution of Conflicts of Interest: In accordance with the ACCME Standards for Commercial Support of CME, The France Foundation and the Pulmonary Fibrosis Foundation will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

Media Disclosure: Your registration, attendance at, and/or participation in this meeting constitutes consent to being photographed, videotaped, or recorded during the meeting by The France Foundation, its educational collaborators, or anyone authorized on behalf of these organizations. You further authorize, without any compensation paid to you, the use of any photographs, videos, or recordings that contain your likeness, image, or voice in any educational, informational, commercial, or promotional materials produced and/or distributed by The France Foundation, its educational collaborators, or anyone authorized by these organizations, as well as on any Internet sites maintained by any of these entities. Images/recordings used for these purposes will not be sold, and no personal information about you or the subject (other than event location and date) will be included in the production of any material.

The France Foundation fully complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant of this activity given by The France Foundation is in need of accommodation, please submit written requests via fax to 860-434-5390.


Event Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

Venue Information:
University of Miami
Street: 1320 South Dixie Highway
City: Miami
State: Florida

ISO Start Time: 2015-03-31T18:15:00